🚚 Order Before 3PM for Same-Day Dispatch • ⚗️ 99%+ Purity Compounds • ✅ Third-Party Tested & Verified • 🔒 Secure Ordering •
UK guide · Updated October 2026

Retatrutide UK: Availability, Legal Status & Research Guide

Is retatrutide available in the UK, when could it be licensed, and how can researchers source retatrutide peptide they can trust? This guide covers the current UK status of retatrutide (LY3437943), what research-grade supply means, and how to check independent HPLC purity testing.

UK licenceNot licensed
StatusPhase 3 trials
Research supply10 / 20 / 40 mg
Purity testHPLC · Janoshik

For in vitro research use only. Not for human or animal use. Nothing on this page is medical or legal advice.

Is retatrutide available in the UK?

Not as a medicine. Retatrutide has no marketing authorisation from the MHRA, the UK medicines regulator. It cannot be prescribed on the NHS or privately, and UK pharmacies cannot dispense it. Outside approved clinical trials, there is no licensed way to obtain retatrutide for human use in the UK.

What is available in the UK is research-grade retatrutide peptide: a lyophilised (freeze-dried) reagent supplied to laboratories for in vitro research. It is not a medicine, it is not intended for people or animals, and it should never be confused with a licensed treatment.

When will retatrutide be available in the UK?

No UK launch date has been announced. Retatrutide is still an investigational compound in the late-stage Phase 3 TRIUMPH clinical trial programme.

  • In July 2026, the developer reported further Phase 3 results and said it plans to submit its first application to the US regulator in the first quarter of 2027.
  • No timeline has been given for a UK application to the MHRA.
  • A UK licence would only follow an MHRA review, so any UK date before then is speculation.

We will update this page as the regulatory picture changes.

Because retatrutide is not a licensed medicine, it cannot lawfully be sold or supplied for human use in the UK. The MHRA has taken enforcement action against unlicensed retatrutide pens and injections sold to the public, and these products carry real risks, including wrong doses, missing active ingredient and contamination.

Research-grade retatrutide is different: it is supplied as a laboratory reagent, clearly labelled not for human or animal use, without dosing instructions or medical claims. Researchers are responsible for using it only within lawful, controlled research. This is general information, not legal advice.

We do not sell pens or injections

Sterling Peptides supplies retatrutide only as lyophilised powder in sealed research vials. We do not sell pens, pre-filled devices or any product intended for human use, and we do not provide dosing or usage advice.

Research-grade retatrutide in the UK

For laboratories, the main questions are identity, purity and traceability. Sterling Peptides, the trading name of Sterling Research Group Ltd (a UK-registered company, no. 17078385), supplies retatrutide from UK-held stock:

  • Independent purity testingEvery batch is purity tested by Janoshik, an independent laboratory, using HPLC before it is listed for sale.
  • UK-held stockOrders before 3PM, Monday to Friday, are normally dispatched the same day by Royal Mail Tracked 24.
  • Three vial sizes10mg, 20mg and 40mg lyophilised vials, to match the scale of your research.
  • Full specificationsMolecular weight, CAS number and storage data published for every compound.

How to spot fake or unverified retatrutide

Because demand is high and no licensed product exists, unverified and counterfeit retatrutide is common. When assessing any research supplier, check for:

  1. A named independent laboratoryAn HPLC purity report from an identifiable third-party lab, not just a percentage on a label.
  2. Correct chemical dataRetatrutide has a molecular weight of about 4731 g/mol and CAS number 2381089-83-2. Missing or wrong data is a warning sign.
  3. A real company behind the shopA registered company name, number and address you can check, and a working contact email.
  4. No pens, doses or weight-loss claimsResearch material is supplied as powder in vials, with no dosing guidance. Pens and “ready-to-use” products are sold for human use and are unlicensed.

Read more about how we test on our Quality & Testing page.

About retatrutide

Retatrutide is a synthetic 39-amino-acid peptide designed as a single agonist at three receptors involved in metabolic signalling: GIP, GLP-1 and glucagon. This “triple agonist” design, often shortened to “reta”, sets it apart from earlier compounds that target one or two of these receptors. A C20 fatty diacid side chain promotes albumin binding and extends its half-life.

For the full structure, mechanism and published literature, see our retatrutide research guide and the retatrutide vs tirzepatide comparison.

Sizes and specifications

NameRetatrutide
Research codeLY3437943
ClassGIP / GLP-1 / glucagon receptor triple agonist
Molecular weight≈ 4731 g/mol
CAS number2381089-83-2
FormLyophilised (freeze-dried) powder
Purity testingHPLC, independent laboratory (Janoshik)
Storage−20 °C, sealed, protected from light and moisture

Further reading

Frequently asked questions

Is retatrutide available in the UK?

Retatrutide is not available in the UK as a licensed medicine. It has no MHRA marketing authorisation and cannot be prescribed or dispensed. Research-grade retatrutide is available in the UK only as a reagent for in vitro laboratory research.

When will retatrutide be available in the UK?

No UK date has been announced. Retatrutide is still investigational. In July 2026 the developer said it plans to file its first application with the US regulator in the first quarter of 2027, and gave no timeline for the UK. Any UK launch would follow an MHRA review, so a date before then is speculation.

Can you buy retatrutide in the UK?

You cannot buy retatrutide in the UK as a medicine, and any pen or injection sold for personal use is unlicensed. Research-grade retatrutide peptide can be bought in the UK from research suppliers as a lyophilised reagent for laboratory use only.

Where can I buy retatrutide peptide in the UK for research?

Sterling Peptides supplies research-grade retatrutide in 10mg, 20mg and 40mg vials from UK-held stock, through our official store at sterling-research.com. Every batch is purity tested by Janoshik using HPLC. It is sold for in vitro research only.

Is it legal to buy retatrutide in the UK?

Retatrutide is not a licensed medicine, so it cannot lawfully be sold or supplied for human use in the UK. Research-grade retatrutide is supplied as a laboratory reagent that is not for human or animal use. Buyers are responsible for using it only within lawful research. This is general information, not legal advice.

How can I tell if retatrutide is fake?

Research material should come with an independent test report from a named laboratory, a molecular weight of about 4731 g/mol, a CAS number of 2381089-83-2 and a supplier you can identify, such as a UK-registered company. Pens, pre-filled devices, dosing instructions and weight-loss claims are warning signs, because no licensed retatrutide product exists in the UK.

How is your retatrutide tested?

Every batch is purity tested by Janoshik, an independent laboratory, using HPLC before it is listed for sale.

How quickly is retatrutide delivered in the UK?

Orders placed before 3PM UK time, Monday to Friday, are normally dispatched the same day by Royal Mail Tracked 24, usually arriving in 1–2 working days.

How should retatrutide be stored?

Store lyophilised vials at −20 °C, sealed and protected from light and moisture.

All products supplied by Sterling Peptides, the trading name of Sterling Research Group Ltd, are strictly for laboratory research and analytical purposes. They are not for human or veterinary consumption, or for medical, diagnostic, therapeutic or veterinary use. Questions: contact@sterling-research.com